StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$8.07M. The highest annual figure on record is -$8.07M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.07M–
FY2024Dec 31, 2024-$43.87M–
FY2023Dec 31, 2023-$22.61M–
FY2022Dec 31, 2022-$26.24M–
FY2021Dec 31, 2021-$23.57M–
FY2020Dec 31, 2020-$23.21M–
FY2019Dec 31, 2019-$22.67M–
FY2018Dec 31, 2018-$24.19M–
FY2017Dec 31, 2017-$20.55M–
FY2016Dec 31, 2016-$14.51M–
FY2015Dec 31, 2015-$14.17M–

More BioLineRx figures

See a number that looks wrong?